MARKET

RLAY

RLAY

Relay Therapeutics, Inc.
NASDAQ
8.61
+0.30
+3.61%
Opening 10:20 12/24 EST
OPEN
8.37
PREV CLOSE
8.31
HIGH
8.66
LOW
8.34
VOLUME
220.44K
TURNOVER
--
52 WEEK HIGH
9.04
52 WEEK LOW
1.775
MARKET CAP
1.49B
P/E (TTM)
-4.9197
1D
5D
1M
3M
1Y
5Y
1D
Interesting RLAY Call Options For February 2026
NASDAQ · 2d ago
Weekly Report: what happened at RLAY last week (1215-1219)?
Weekly Report · 2d ago
CANCER DRUG DEVELOPERS SECURE REGULATORY CLARITY AS FDA RESHAPES APPROVAL STANDARDS
Reuters · 12/16 17:18
Weekly Report: what happened at RLAY last week (1208-1212)?
Weekly Report · 12/15 10:00
Relay Therapeutics Reports 'Robust Activity' For Precision Breast Cancer Drug
Benzinga · 12/12 18:30
Relay Therapeutics Price Target Raised to $13.00/Share From $6.00 by Wells Fargo
Dow Jones · 12/12 16:41
Relay Therapeutics Raised to Overweight From Equal-Weight by Wells Fargo
Dow Jones · 12/12 16:41
Wells Fargo Upgrades Relay Therapeutics to Overweight, Raises Price Target to $13
Benzinga · 12/12 16:31
More
About RLAY
Relay Therapeutics Inc. is a clinical-stage precision medicine company. The Company’s initial focus is on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. Its Dynamo platform integrates an array of computational and experimental approaches designed to drug protein targets that have previously been intractable or inadequately addressed. The Company’s lead product candidates, such as RLY-2608. It is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including RLY-2608. RLY-2608 is an allosteric, pan-mutant and isoform-selective phosphoinostide 3 kinase alphas (PI3Kα), inhibitor in clinical development. It is the lead program in its efforts to discover and develop mutant selective inhibitors of PI3Kα.

Webull offers Relay Therapeutics Inc stock information, including NASDAQ: RLAY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RLAY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RLAY stock methods without spending real money on the virtual paper trading platform.